Clinical and Immunological Factors Associated with the Progression of Lupus Nephritis in a Population from the Colombian Caribbean.

UNLABELLED

Lupus nephritis represents a significant immune-mediated glomerulonephritis, constituting the most important organ involvement induced by systemic lupus erythematosus (SLE), with variable epidemiology and clinical presentation among populations.

OBJECTIVE

to identify clinical and immunological factors associated with the progression of lupus nephritis in a population from the Colombian Caribbean.

METHODS

we evaluated 401 patients diagnosed with SLE and lupus nephritis, treated at a reference center in the Colombian Caribbean, gathering data recorded in medical records.

RESULTS

A proportion of 87% were female, with a median age of 42 years. Most patients presented with proliferative classes (90%), with class IV being the most common (70%). A proportion of 52% of patients did not respond to treatment, which is described as the lack of complete or partial response, while 28% had a complete response. A significant decrease in hemoglobin, glomerular filtration rate, and proteinuria was identified by the third follow-up ( < 0.001), along with an increase in creatinine, urea, and hematuria ( < 0.001). Patients with initial proteinuria > 2 g/day were found to be 27 times more likely to be non-responders ( < 0.001). Mortality was associated with the presence of serum creatinine >1.5 mg/dL ( = 0.01) (OR: 1.61 CI 95% 0.75-3.75) and thrombocytopenia ( = 0.01) (OR: 0.36; CI 95% 0.12-0.81).

CONCLUSIONS

identifying factors of progression, non-response, and mortality provides an opportunity for more targeted and personalized intervention, thereby improving care and outcomes for patients with lupus nephritis.